CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand

U.S. Centers for Disease Control and Prevention (CDC) Reports a Significant Year-Over-Year Increase in Nationwide Rabies Exposures andRabies Immunoglobulin Utilization KedRAB is One of Only Two ...
Yahoo Finance

GC Biopharma Launches ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults, an Immune Globulin for the Treatment of Primary Humoral Immunodeficiency (PI ...

TEANECK, N.J., Sept. 9, 2024 /PRNewswire/ -- GC Biopharma USA, Inc. announced the launch and distribution of its immunoglobulin (IG) product ALYGLO (immune globulin intravenous, human-stwk), the ...
Business Wire

AOM Infusion Selected as a Limited Distribution Specialty Pharmacy for QIVIGY®, A New Immune Globulin Therapy

ARLINGTON, Texas--(BUSINESS WIRE)--AOM Infusion (“AOM”), a leading specialty infusion pharmacy and provider, today announced it has joined Kedrion Biopharma’s limited distribution network for QIVIGY ® ...
Medical Xpress

New lab-made antibody matches IVIG effectiveness at lower doses in mice

Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently ...
Monthly Prescribing Reference

Qivigy Approved for Primary Humoral Immunodeficiency in Adults

The product is expected to be available in early 2026. The Food and Drug Administration (FDA) has approved Qivigy (immune globulin intravenous [IV], human-kthm) 10% solution for the treatment of ...

Intravenous Immunoglobulin Market Size Worth USD 30.83 Billion by 2035, Growing at 7.49% CAGR – SNS Insider

U.S. Intravenous Immunoglobulin Market to Reach USD 16.58 Billion and Europe USD 8.64 Billion by 2035 as Neurological ...